Indianapolis-based Eli Lilly and Co. and federal prosecutors are discussing a settlement of a civil and criminal investigation into the company’s marketing of the antipsychotic drug Zyprexa that could result in Lilly’s paying more than $1 billion to federal and state governments, reports the New York Times. If a deal is reached, the fine would be the largest ever paid by a drug company for breaking the federal laws that govern how drug makers can promote their medicines.
Wednesday, January 30, 2008
Lilly in Settlement Talks With U.S.
Indianapolis-based Eli Lilly and Co. and federal prosecutors are discussing a settlement of a civil and criminal investigation into the company’s marketing of the antipsychotic drug Zyprexa that could result in Lilly’s paying more than $1 billion to federal and state governments, reports the New York Times. If a deal is reached, the fine would be the largest ever paid by a drug company for breaking the federal laws that govern how drug makers can promote their medicines.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment